Chiltern and Medidata Mark 10-Year Anniversary Milestone in Bringing Cloud-based Technology to Clinical Development
June 13 2017 - 8:30AM
Business Wire
Medidata (NASDAQ:MDSO), the leading global provider of
cloud-based technology and data analytics for clinical research,
and Chiltern, a leading global contract research organization
(CRO), today announced an anniversary milestone in their strategic
partnership.
The two organizations have been working together for 10 years to
deliver world-class clinical development services to Chiltern’s
broad customer base via the Medidata Clinical Cloud®.
Known for its collaborative approach designed around its
clients, Chiltern offers comprehensive programs and functional
service provisions (FSP) to the global pharmaceutical,
biotechnology and device markets. The organization has deep
experience in oncology, dermatology, endocrine and metabolic,
gastroenterology, respiratory, ophthalmology and neuroscience,
among others — enabling its 4,300+ staff to fold unique therapeutic
expertise into its wide range of clinical development and data and
analytics services.
In its 35 years of operations, Chiltern has spent the last
decade bolstering its R&D and scientific expertise with
Medidata’s unified technology platform. Chiltern joined Medidata’s
Partner Program in 2007, when it became accredited in Medidata’s
industry-leading electronic data capture, management and reporting
tool, Medidata Rave®. Since then, Chiltern has continued to
increase its use of the Medidata platform, further enhancing its
innovative research programs with accreditations across Medidata’s
portfolio of integrated solutions, including: Medidata Coder®,
Medidata Balance®, Medidata TSDV, Safety Gateway and Medidata
Patient Cloud®. Today, Chiltern has over 130 Rave-certified
builders on staff and has built over 750 studies on the Medidata
platform.
“As the global life sciences landscape continues to evolve, it’s
important that Chiltern aligns itself with innovative technology
partners that have the agility, scale and insight to meet the most
rigorous aspects of clinical development today—from real-time
analytics to risk-based monitoring, biometrics and
pharmacovigilance. Medidata is one of those partners,” said Mark
Penniston, Chiltern’s executive vice president, clinical analytics,
and general manager. “Leveraging Medidata’s end-to-end platform has
enabled us to effectively allocate study resources, standardize
data and seamlessly integrate clinical and operational information
across our customers’ global R&D programs. We’ve spent the past
10 years helping our customers drive clinical success on the
Medidata Clinical Cloud, and we look forward to many more.”
“Medidata’s extensive partnership with Chiltern reflects our
shared commitment to marrying cutting-edge technology, data-driven
processes and scientific excellence to develop better therapies for
patients,” said Mike Capone, Medidata chief operating officer.
“Chiltern is a collaborative organization driving personalized
R&D programs for its global customers, and as Chiltern’s cloud
platform of choice, we’re proud to provide them with the tools and
techniques needed to ensure clinical data quality, study accuracy
and operational speed. We look forward to further strengthening our
partnership and celebrating the continued success of our customers’
medical advancements together.”
Chiltern was the winner of Medidata’s inaugural “Architect of
Hope” Award in 2016, an award in recognition of the CRO’s
successful partnership with a major biopharmaceutical company. The
organization will continue to use Medidata’s study conduct
solutions and patient engagement tools in a number of its upcoming
studies, as well as tap into Medidata’s latest mobile health
(mHealth) offering, Medidata Enroll, for electronic informed
consent.
Attending the DIA 2017 Annual Meeting in Chicago, June 18-22? Be
sure to visit Medidata at booth 1318 and Chiltern at booth 1807 for
more on our respective clinical research solutions and
services.
Connect with Medidata
- Read our blog, Geeks Talk Clinical
- Tweet this: .@Chiltern_CRO &
@Medidata celebrate 10 yrs of bringing #cloud #tech & #data
analytics to #clinicalresearch: http://ow.ly/vSLl30cx4zV
- Follow us on Twitter: @Medidata
- Find us on LinkedIn
About Chiltern
Chiltern, a global contract research organization, is a leading
provider of clinical services and solutions in a variety of
therapeutic areas with engagement models for biopharmaceutical and
medical device industries. Chiltern’s team of more than 4,300,
located across 47 countries, provides comprehensive Clinical
Development, Medical & Scientific Affairs, Data & Analysis,
Pharmacovigilance and Strategic Regulatory services using a
collaborative approach for more efficient clinical trials. Visit
Chiltern.com to learn more about how Chiltern is Designed Around
You®.
About Medidata
Medidata is reinventing global drug and medical device
development by creating the industry's leading cloud-based
solutions for clinical research. Through our advanced applications
and intelligent data analytics, Medidata helps advance the
scientific goals of life sciences customers worldwide, including
over 850 global pharmaceutical companies, biotech, diagnostic and
device firms, leading academic medical centers, and contract
research organizations.
The Medidata Clinical Cloud® brings a new level of quality and
efficiency to clinical trials that empower our customers to make
more informed decisions earlier and faster. Our unparalleled
clinical trial data assets provide deep insights that pave the way
for future growth. The Medidata Clinical Cloud is the primary
technology solution powering clinical trials for 18 of the world's
top 25 global pharmaceutical companies and is used by 18 of the top
25 medical device developers—from study design and planning through
execution, management and reporting.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20170613005375/en/
Medidata:Investor:Medidata SolutionsAnthony
D’Amico, +1 732-767-4331adamico@mdsol.comorMedia:Medidata
SolutionsErik Snider, +1
646-362-2997esnider@mdsol.comorChiltern:Media:SCORR
MarketingLea Studer, 308-237-5567lea@scorrmarketing.com
Medidata Solutions (NASDAQ:MDSO)
Historical Stock Chart
From Mar 2024 to Apr 2024
Medidata Solutions (NASDAQ:MDSO)
Historical Stock Chart
From Apr 2023 to Apr 2024